LOTUS BIOTECH DEVELOPMENT CORP. (LBTD) financial statements (2021 and earlier)
Company profile
| Business Address |
28202 N 58TH ST. CAVE CREEK, AZ 85331 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| SIC | 7812 - Motion Picture and Video Tape Production (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 0 | 2 | 0 | 4 | ||
| Cash and cash equivalents | 0 | 2 | 0 | 4 | ||
| Total current assets: | 0 | 2 | 0 | 4 | ||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 5 | |||||
| Total noncurrent assets: | 5 | |||||
| TOTAL ASSETS: | 5 | 2 | 0 | 4 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 15 | 9 | 18 | 1 | ||
| Other undisclosed accounts payable and accrued liabilities | 15 | 9 | 18 | 1 | ||
| Due to related parties | 51 | 38 | 34 | 12 | ||
| Total current liabilities: | 67 | 47 | 52 | 13 | ||
| Noncurrent Liabilities | ||||||
| Total liabilities: | 67 | 47 | 52 | 13 | ||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | (61) | (45) | (52) | (9) | ||
| Common stock | 1 | 2 | 0 | 0 | ||
| Additional paid in capital | 867 | 101 | 103 | 104 | ||
| Accumulated deficit | (929) | (148) | (155) | |||
| Other undisclosed stockholders' equity attributable to parent | (114) | |||||
| Total stockholders' equity: | (61) | (45) | (52) | (9) | ||
| TOTAL LIABILITIES AND EQUITY: | 5 | 2 | 0 | 4 | ||
Income statement (P&L) ($ in thousands)
| 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|---|
| Gross profit: | 3 | 3 | |||
| Operating expenses | (781) | (32) | (1) | ||
| Operating loss: | (778) | (29) | (1) | ||
| Nonoperating expense (Other Nonoperating expense) | (0) | ||||
| Net loss: | (778) | (29) | (1) | (0) | |
| Other undisclosed net income (loss) attributable to parent | (3) | 10 | (41) | (62) | |
| Net loss available to common stockholders, diluted: | (781) | (19) | (42) | (62) | |
Comprehensive Income ($ in thousands)
| 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|---|
| Net loss: | (778) | (29) | (1) | (0) | |
| Comprehensive loss, net of tax, attributable to parent: | (778) | (29) | (1) | (0) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.